|
| |
| |
|
|
|
2003 News Releases
- Dec 30,
2003 - First closing Of $4,000,000 on announced financing
- Dec 17, 2003 - N.O.L. letter received from Health Canada for
Refractory Severe Chronic Pain
- Dec 11, 2003 - WEX announces $6,000,000 Financing
- Nov 27, 2003 - Clinical Development
- Contract Manufacturing
- Nov 26, 2003 - Tectin™ Development
Update
- Nov 19, 2003 - SFDA Meeting For Phase II Clinical Trial In
China
- Nov 1, 2003 - Phase II-A Interim
Analysis On Tectin™ For
Severe Cancer Related Pain to be presented at Scientific Meeting
- Oct 31, 2003 - Stock Options Granted
- Oct 30, 2003 - Private Placement Closed
- Oct 21, 2003 - Interim Analysis
Completed For Tectin™ Phase
IIA Severe Cancer Related Pain Trial
- Oct 6, 2003 - Stock Options Granted
- Sep 30, 2003 - Additional Route
Of Administration For Pivotal Study Tectin™ / Tetrodin™
- Sep 18, 2003 - Private Placement Closed
- Sep 16, 2003 - Brokered Private Placement
- Aug 27, 2003 - Non-Brokered Private Placement
- Aug 22, 2003 - Private Placement Closed
- Aug 21, 2003 - Non-Brokered Private Placement
- Aug 20, 2003 - Patent Method of Local Anesthesia and Analgesia
issued by USPTO
- Aug 14, 2003 - Private Placement Closed
- Aug 5, 2003 - Phase IIA Interim Results Expected
- Jul 22, 2003 - Non-Brokered Private Placement
- Jun 25, 2003 - Non-Brokered Private Placement
- May 27, 2003 - Trademark `Tetrodin` allowed in Canada and in the United States
- May 26, 2003 - Patent `Method of purifying Tetrodotoxin` issued
by USPTO
- May 23, 2003 - Patent `A Method of Extracting Tetrodotoxin`
issued by USPTO
- May 22, 2003 - Patent `Composition of Sodium Channel Blocking
Compound` issued by USPTO
- May 6, 2003 - Appointment To Board Of Directors
- Apr 21, 2003 - New Site Added
To Current Study
- Apr 11, 2003 - New Appointment Made To Investor Relations Department
- Apr 9, 2003 - Good Manufacturing Practices Licenses Received
- Mar 28, 2003 - Appointment to Scientific Advisory Board
- Mar 3, 2003 - All aspects of Phase I Clinical Trials in China
completed
- Feb 24, 2003 - Closing of Non-Brokered
Private Placement
- Feb 19, 2003 - Phase II Clinical Trial for Tectin™ approved
in China
- Feb 3, 2003 - Second Dose Level
Of Phase II a Clinical Trial Completed In Canada
- Jan 3, 2003 - License Agreement
Sealed with Closing of Private Placement
< 2002 news :: 2004 news >
|
 |
|
|
|
| Home | News | Corporate | Products | Clinical Trials | Investors | Licensing | Contact | |
|
Copyright WEX Pharmaceuticals Inc. All rights reserved.
Privacy Policy | Disclaimer
Website designed by Attention Media.
|
|
